Hemei Pharmaceutical Delays Global Offering and Listing
Start here
On 5 November 2026, Ming Pao Daily Economic reported that Hemei Pharmaceutical (0054), after its subscription closed at noon yesterday, announced after market close that in view of current market conditions it would delay its global offering and listing and would begin refunds from 9 November. The company stressed that it remains committed to completing the global offering and listing at an appropriate time. The report noted that this is the sixth share to announce a delay to its listing this year.
Generated by AI from reporting · updated 2 hours ago
Reporting timeline
Follow the reports to explore different aspects of the story.
- 明報·每日經濟Hemei Pharmaceutical Delays Global Offering and Listing, Sixth New Stock Halted This Year
Hemei Pharmaceutical (0054), after its subscription closed at noon yesterday, announced after market close that it would delay its global offering and listing in view of current market conditions, with refunds to begin from 9 November. The company stressed it remains committed to completing the global offering and listing at an appropriate time, becoming the sixth share to announce a delayed listing this year.
Activity over time for this story
There are not enough continuous observations to draw a trend yet.